Tesla Inc. (NASDAQ: TSLA) may be a hard company to judge on individual earnings reports, particularly when it is still valued at nearly 200-times forward earnings expectations for a company that has been public for 15 years. The market has judged the Tesla earnings report for Q3/2025 as a miss, and the stock opened lower on Thursday morning’s post-earnings reaction.
While Tesla was down 3.5% at $423.50 about 30 minutes after the opening bell, Tesla’s performance metrics are mixed. Its stock was last seen up just 4.6% YTD, but up 93% versus a year ago.
One key issue here is that many of Wall Street’s analysts are still quite positive on Tesla despite weak earnings. Even the more cautious analysts did not slash their price targets drastically on top of existing “Sell” ratings. And some price targets were actually raised even higher.
Oggonomics has tracked some of the analyst calls issued on Thursday morning. There will be more analyst calls coming, and these are very brief descriptions to keep it moving.
Tesla was reiterated as Overweight at Cantor Fitzgerald and its price target was raised to $510 from $355 in that call.
Canaccord Genuity maintained its Buy rating on Tesla but trimmed its price target down to $482 from $490.
Deutsche Bank maintained its Hold rating but raised its target price to $440 from $435.
Goldman Sachs maintained its Neutral rating with a $400 price target.
Mizuho reiterated its Outperform rating and raised its price target to $485 from $450.
Morgan Stanley maintained its Overweight rating and $10 price target, noting that margins were in-line as it is “navigating a dignified exit from the steering-wheel-having auto business while maintaining a resilient FCF profile.” Tesla looking forward will be tied to Elon’s ability to “steal the fire” on autonomy in the face of competition from Mag 7 & beyond.
RBC Capital Markets reiterated its Outperform rating and its $500 price target.
Truist Securities reiterated its Hold rating, but the firm still hiked its price target up to $406 from $280.
Wedbush Securities has reiterated its Outperform rating and $600 price target. Ives believes that the worst days of Tesla are behind the company and that China remains a key to Tesla. Robotics and autonomous are key, with autonomous vehicles worth $1 trillion alone.
CFRA (S&P) has maintained its Sell rating and its $325 price target. Some reasons cited are based on a 2027 P/E of 120x being driven by long-term growth expectations. Along with the earnings miss, CFRA’s report cited that the release and conference call did not do enough to address concerns about the near-term earnings growth trajectory. It also noted that management passed on a couple of conference call questions about future products. In the absence of new developments, CFRA continues to view the stock as susceptible to multiple contraction.
Oggonomics has assigned each rating and price target above to each firm by name. Oggonomics does not have any formal rating or price target on Tesla and its key competitors. Investors should also keep in mind that no single analyst call should ever be the sole reason to buy or sell any stock. Analysts can be wrong, and their calls never come with assurances or money-back guarantees.
